Inventor
GROGAN MICHAEL J
US44 patents
⚠️ This page may combine multiple inventors who share the name “GROGAN MICHAEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFINITY PHARMACEUTICALS INC
20 patentsUS7812164B2Oct 12, 2010
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC84 citations99
US8017648B2Sep 13, 2011
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC37 citations96
US10406139B2Sep 10, 2019
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC8 citations92
US9492435B2Nov 15, 2016
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC13 citations92
US9145422B2Sep 29, 2015
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC16 citations92
US10314827B2Jun 11, 2019
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US10045970B2Aug 14, 2018
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US9951083B2Apr 24, 2018
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US9669011B2Jun 6, 2017
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US7851637B2Dec 14, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
INFINITY PHARMACEUTICALS INC13 citations81
US8349814B2Jan 8, 2013
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations74
US7947663B2May 24, 2011
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC6 citations74
US11602527B2Mar 14, 2023
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC0 citations73
US11007181B2May 18, 2021
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC1 citations73
US10821102B2Nov 3, 2020
Methods of use of cyclopamine analogs
INFINITY PHARMACEUTICALS INC1 citations73
US9108989B2Aug 18, 2015
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC1 citations63
US8629125B2Jan 14, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations63
US8802119B2Aug 12, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC0 citations52
US8802064B2Aug 12, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC0 citations52
US9951089B2Apr 24, 2018
Methods of treating a fatty acid amide hydrolase-mediated condition
INFINITY PHARMACEUTICALS INC0 citations50
CASTRO ALFREDO C
10 patentsUS8227509B2Jul 24, 2012
Methods of use of cyclopamine analogs
CASTRO ALFREDO C72 citations98
US8895576B2Nov 25, 2014
Methods of use of cyclopamine analogs
CASTRO ALFREDO C16 citations92
US8426436B2Apr 23, 2013
Heterocyclic cyclopamine analogs and methods of use thereof
CASTRO ALFREDO C19 citations92
US8293760B2Oct 23, 2012
Cyclopamine lactam analogs and methods of use thereof
CASTRO ALFREDO C19 citations92
US8541581B2Sep 24, 2013
Inhibitors of fatty acid amide hydrolase
CASTRO ALFREDO C3 citations63
US8546564B2Oct 1, 2013
Inhibitors of fatty acid amide hydrolase
CASTRO ALFREDO C0 citations52
US8609706B2Dec 17, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8304428B2Nov 6, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8178690B2May 15, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US7745464B2Jun 29, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
INFINITY DISCOVERY INC
4 patentsUS7994191B2Aug 9, 2011
Heterocyclic cyclopamine analogs and methods of use thereof
INFINITY DISCOVERY INC29 citations92
US7964590B2Jun 21, 2011
Cyclopamine lactam analogs and methods of use thereof
INFINITY DISCOVERY INC29 citations92
US7648994B2Jan 19, 2010
Heterocyclic cyclopamine analogs and methods of use thereof
INFINITY DISCOVERY INC35 citations92
US7928244B2Apr 19, 2011
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
INFINITY DISCOVERY INC0 citations50
BEHNKE MARK L
4 patentsUS9149465B2Oct 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations49
US8765735B2Jul 1, 2014
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L1 citations49
US8957049B2Feb 17, 2015
Inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39
US8927551B2Jan 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39